Canopy Growth (TSX:WEED) Doubles Down on Colombia: A Path to Success

Canopy Growth Corp.’s (TSX:WEED)(NYSE:CGC) latest foray into Colombia indicates that it is focused on boosting profitability.

| More on:
Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

Colombia’s appeal as a low cost jurisdiction in which to cultivate marijuana saw leading Canadian cultivator Canopy Growth (TSX:WEED)(NYSE:CGC) double down on its operations in the equatorial nation. 

Expanding operations in Latin America

In July 2018 Canopy had announced that it had acquired Spectrum Cannabis Colombia in a deal worth up to $96 million. Spectrum owns a 126-hectare farm in the south-central department of Huila, which is renowned for its agricultural industry including coffee and fruit growing as well as illegal marijuana and coca cropping.

Colombia, because of its ideal climatic conditions, has a large agricultural industry and a long history of cultivating cut flowers, orchids, fruits and coffee, which sees it ranked as the third-largest coffee producing nation globally.

It isn’t difficult to understand why agriculture is the dominant industry in Huila.  The department is endowed with rich volcanic soils, temperate climate zones, even hours of sunlight, generous rainfall and low labour costs.

Spectrum’s property has an available water supply from a natural fresh-water lagoon and now has 13.6 million square feet licensed to produce psychoactive and non-psychoactive cannabis compared to 4.5 million about a year ago. This makes Canopy’s permitted operation in Huila one of the largest in the world. Construction of the facility reportedly began in summer 2018, and Canopy anticipates that it will be operational after one year.

It is speculated by some analysts that cannabis cultivators in Colombia can produce dried flower for $0.50 per gram, which is less than a tenth of Canopy’s fiscal fourth quarter 2019’s cost of sales of $5.47 per gram. Leading Colombian cultivator PharmaCielo believes that it can cultivate dried flower for as little as $0.05 per gram which is a tenth of what analysts believe the industry average will be in the South American nation.

Colombia’s climate makes open air greenhouse cultivation feasible, meaning that compared to energy intensive climate-controlled greenhouses in North America, which in combination with significantly lower wages means operating expenses are considerably lower.

It is the massive consumption of electricity for 24-hour climate-controlled indoor greenhouses in Canada, which is the most significant cost.

According to U.S. government research, a 5,000 square foot indoor cultivation facility in Colorado uses 66-times more electricity than an average household and marijuana cropping uses 1% of all electricity consumed nationally. It has been estimated by industry insiders that electricity expense makes up over a quarter of all direct costs incurred to grow a gram of marijuana.

Those factors along with Canopy’s disappointing 2019 results, highlight why it needs to build its international presence and pivot its cultivation activities to lower cost jurisdictions such as Colombia.

Mid-last month, Canopy announced that it had entered into an agreement with Colombia-based pharmaceutical company Procaps for the preparation of a range of cannabis oil-based products. Procaps is an ideal distribution partner for Canopy because it already manufacturers a range of over-the-counter medications and nutritional supplements and exports to 50 markets globally, including those like the U.S. which are highly regulated.

It also provides Canopy with a processing and manufacturing capability in Colombia with a pharmaceutical company that has existing large-scale global distribution.

Foolish takeaway

If Canopy pivots its cultivation operations to Colombia, that will go a long way to reducing costs and potentially improving the quality of its product because of the Andean nation’s favourable climate, soil and legendary marijuana strains Colombia Golden and Punto Rojo.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Matt Smith has no position in any of the stocks mentioned.

More on Cannabis Stocks

IMAGE OF A NOTEBOOK WITH TFSA WRITTEN ON IT
Cannabis Stocks

TFSA Investors: 2 U.S. Stocks I’m Never Selling

Canadians looking to diversify their portfolios and gain exposure to U.S. stocks can purchase shares of high-growth companies such as…

Read more »

A cannabis plant grows.
Cannabis Stocks

Aurora Cannabis (TSX:ACB) Keeps Burning Cash as Revenue Falls

Aurora Cannabis (TSX:ACB)(NASDAQ:ACB) is still losing money. Its revenue is declining, too.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

Why Canopy Growth Stock Climbed as Much as 20% on Monday

A glimmer of hope from the U.S. Congress may lead to renewed interest in marijuana investing.

Read more »

TSX Today
Cannabis Stocks

TSX Today: What to Watch for in Stocks on Friday, July 15

A continued selloff in metals prices is likely to pressure the commodity-heavy TSX Composite benchmark at the open today.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

With the Cannabis Industry Trading Ultra-Cheap, Organigram Stock Looks Like a Screaming Buy!

After selling off for years, Organigram stock now offers tonnes of value and is easily one of the best cannabis…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Canopy Growth Stock: The Only Cannabis Stock to Consider Long Term

The cannabis stock industry remains an incredibly high risk one, but Canopy Growth (TSX:WEED)(NYSE:CGC) stock provides the best opportunity for…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Should You Stay Away From HEXO Stock?

HEXO (TSX:HEXO)(NASDAQ:HEXO) stock is on a downward spiral, and there is little hope it is going to recover soon.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why Did Aurora Cannabis (TSX:ACB) Stock Plunge 75% in 2022?

A prominent cannabis stock has plunged by 75% in 2022, as the company’s losses continue to mount in the face…

Read more »